Rallybio receives Nasdaq bid price deficiency notice; faces potential delisting

Rallybio Corp

Notice on Feb 24, 2025: closing bid price below $1.00 for 30 consecutive business days.
Company has 180 days, until August 25, 2025, to regain compliance by closing at $1.00+ for 10 days.
If not cured, may qualify for additional 180-day period by transferring to Nasdaq Capital Market.
Failure to regain compliance could lead to delisting and potential appeal to Nasdaq Hearings Panel.
No immediate impact on trading; stock continues to list on Nasdaq under other requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.